TITLE

Heart failure deaths drop among blacks

PUB. DATE
August 1998
SOURCE
Jet;08/31/98, Vol. 94 Issue 14, p23
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Focuses on a study quoted by the newspaper USA Today, highlighting a decrease in heart failure deaths among blacks. Statistical information representing the decrease; Information on a report by the Centers for Disease Control and Prevention (CDC); Statements from Janet Croft, a CDC epidemiologist.
ACCESSION #
1030928

 

Related Articles

  • Racial and ethnic differences in subclinical myocardial function: the Multi-Ethnic Study of Atherosclerosis. Fernandes, Verônica Rolim S.; Cheng, Susan; Yu-Jen Cheng; Rosen, Boaz; Agarwal, Sachin; McClelland, Robyn L.; Bluemke, David A.; Lima, João A. C. // Heart;Mar2011, Vol. 97 Issue 5, p405 

    Background Racial/ethnic differences in the incidence and severity of heart failure (HF) are not well understood, but may be related to pre-existing variations in myocardial function. Objective To examine racial/ethnic differences in regional myocardial function among asymptomatic individuals...

  • Heart Failure in Blacks May Signal 'Different Disease'.  // Black Issues in Higher Education;06/20/2002, Vol. 19 Issue 9, p26 

    Reports on the emerging database of genetic variations in Afro Americans that could explain the differences in their response to traditional heart-failure therapies. Factors which suggest that the heart failure in Afro-Americans is likely to be a different disease; Possible way to explain why...

  • Fixed-Dose Isosorbide Dinitrate-Hydralazine: Race-Based Cardiovascular Medicine Benefit or Mirage? Ferdinand, Keith C. // Journal of Law, Medicine & Ethics;Fall2008, Vol. 36 Issue 3, p458 

    Race is not a scientific category, but African Americans have increased prevalence and severity of heart failure. The African American Heart Failure trial showed the benefit of a combination of isosorbide dinitrate (a nitric oxide donor) and hydralazine (an antioxidant). Future research may...

  • Flaws in the U.S. Food and Drug Administration's Rationale for Supporting the Development and Approval of BiDil as a Treatment for Heart Failure Only in Black Patients. Ellison, George T. H.; Kaufman, Jay S.; Head, Rosemary F.; Martin, Paul A.; Kahn, Jonathan D. // Journal of Law, Medicine & Ethics;Fall2008, Vol. 36 Issue 3, p449 

    The U.S. Food and Drug Administration's (FDA) rationale for supporting the development and approval of BiDil (a combination of hydralazine hydrochloride and isosorbide dinitrate; H-I) for heart failure specifically in black patients was based on under-powered, post hoc subgroup analyses of two...

  • Drug targeting: is race enough? Wadman, Meredith // Nature;6/23/2005, Vol. 435 Issue 7045, p1008 

    Discusses the expected approval in the U.S. of the first drug targeted to a specific racial group and the debate it generated about the future of personalized medicine. Recommendation of a Food and Drug Administration advisory committee to approve BiDil, a drug for congestive heart failure, for...

  • MORE NEWS BRIEFS. Dailey, Kate // Men's Health;Nov2004, Vol. 19 Issue 9, p42 

    Presents news briefs concerning health in the U.S. as of November 2004. Efficacy of the drug BiDil for the African Americans with heart failure; Development of a hearing aid that uses artificial intelligence.

  • Association of Aldosterone Synthase Polymorphism (CYP11B2 -344T>C) and Genetic Ancestry with Atrial Fibrillation and Serum Aldosterone in African Americans with Heart Failure. Bress, Adam; Han, Jin; Patel, Shitalben R.; Desai, Ankit A.; Mansour, Ibrahim; Groo, Vicki; Progar, Kristin; Shah, Ebony; Stamos, Thomas D.; Wing, Coady; Garcia, Joe G. N.; Kittles, Rick; Cavallari, Larisa H. // PLoS ONE;Jul2013, Vol. 8 Issue 7, p1 

    The objective of this study was to examine the extent to which aldosterone synthase genotype (CYP11B2) and genetic ancestry correlate with atrial fibrillation (AF) and serum aldosterone in African Americans with heart failure. Clinical data, echocardiographic measurements, and a genetic sample...

  • Syphilis: Still a threat in our communities.  // New York Amsterdam News;10/14/99, Vol. 90 Issue 42, p42 

    Reports on the finding by the United States Centers for Disease Control and Prevention (CDC) that Afro-Americans are 34 times more likely to get infected with syphilis than whites. Decline in syphilis rates across the country; Concentration of new syphilis cases in 28 counties in the South;...

  • Cancer: UGA College of Public Health cancer survival study uncovers wide racial disparities.  // Biomedical Market Newsletter;3/21/2012, Vol. 21, p1 

    The article presents information on the African Americans in Georgia that have poor survival rates as a patient of cancer.

  • 'Enough is enough': the HIV/AIDS epidemic among black Americans. Volansky, Rob // Infectious Disease News;Feb2009, Vol. 22 Issue 2, p1 

    This article discusses the prevalence of HIV/AIDS among African-Americans.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics